8-Oxoguanine Targeted by 8-oxoguanine DNA Glycosylase 1 (OGG1) is Central to Fibrogenic Gene Activation Upon Lung Injury
Overview
Authors
Affiliations
Reactive oxygen species (ROS) are implicated in epithelial cell-state transition and deposition of extracellular matrix upon airway injury. Of the many cellular targets of ROS, oxidative DNA modification is a major driving signal. However, the role of oxidative DNA damage in modulation profibrotic processes has not been fully delineated. Herein, we report that oxidative DNA base lesions, 8-oxoG, complexed with 8-oxoguanine DNA glycosylase 1 (OGG1) functions as a pioneer factor, contributing to transcriptional reprogramming within airway epithelial cells. We show that TGFβ1-induced ROS increased 8-oxoG levels in open chromatin, dynamically reconfigure the chromatin state. OGG1 complexed with 8-oxoG recruits transcription factors, including phosphorylated SMAD3, to pro-fibrotic gene promoters thereby facilitating gene activation. Moreover, 8-oxoG levels are elevated in lungs of mice subjected to TGFβ1-induced injury. Pharmacologic targeting of OGG1 with the selective small molecule inhibitor of 8-oxoG binding, TH5487, abrogates fibrotic gene expression and remodeling in this model. Collectively, our study implicates that 8-oxoG substrate-specific binding by OGG1 is a central modulator of transcriptional regulation in response to tissue repair.
Redox regulation: mechanisms, biology and therapeutic targets in diseases.
Li B, Ming H, Qin S, Nice E, Dong J, Du Z Signal Transduct Target Ther. 2025; 10(1):72.
PMID: 40050273 PMC: 11885647. DOI: 10.1038/s41392-024-02095-6.
Obermann T, Sakshaug T, Kanagaraj V, Abentung A, de Sousa M, Hagen L Redox Biol. 2024; 79():103461.
PMID: 39662289 PMC: 11697278. DOI: 10.1016/j.redox.2024.103461.
Pan L, Wang K, Hao W, Xue Y, Zheng X, Basu R PLoS Pathog. 2024; 20(10):e1012616.
PMID: 39413143 PMC: 11515973. DOI: 10.1371/journal.ppat.1012616.
Ma Y, Guo J, Rao H, Xin J, Song X, Liu R J Extracell Vesicles. 2024; 13(9):e12505.
PMID: 39235072 PMC: 11375530. DOI: 10.1002/jev2.12505.
The potential for OGG1 inhibition to be a therapeutic strategy for pulmonary diseases.
Pan L, Boldogh I Expert Opin Ther Targets. 2024; 28(3):117-130.
PMID: 38344773 PMC: 11111349. DOI: 10.1080/14728222.2024.2317900.